Corify funded by Two Torres Quevedo Programs

We are proud to announce that Corify has been awarded funding from two Torres Quevedo programs, a major recognition of our innovative work and dedication to advancing healthcare technology! 🎉

The Torres Quevedo Program, funded by the Spanish Ministry of Science and Innovation, supports R&D projects by helping companies like ours recruit top research talent. It provides three-year funding for RubĂ©n Molero and Ismael Hernández, Post-doctoral researchers to carry out cutting-edge research and development projects that directly contribute to Spain’s scientific and technological progress.

This funding will allow us to further accelerate our work in non-invasive cardiac mapping, a breakthrough technology designed to improve the diagnosis and treatment of heart conditions. The financial support covers up to 70% of the researcher’s salary, which is a significant boost, allowing us to focus more on innovation and creating a lasting impact on patient care.

Being selected for the Torres Quevedo Program is a huge honor and a testament to Corify’s commitment to excellence in healthcare innovation. We are incredibly proud to be recognized by such a prestigious initiative that values scientific contribution and technological advancement. 🌟 Stay tuned for more updates as we take this exciting journey forward!

Grant PTQ2023-013018 and PTQ2023-012972 funded by MICIU/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”.

#Innovation #Healthcare #R&D #TorresQuevedo #Funding #Corify #NonInvasiveCardiacMapping #ScienceAndTechnology #HeartHealth

Related posts

Corify Care had a strong presence at the European Heart Rhythm Association (EHRA) Congress 2025 in Vienna, with multiple scientific communications featuring...

Last September, Corify Care successfully concluded the DIDIMO Project (Personalized Cardiac Digital Twin to Improve the Development of Medical Devices and Cardiac...

Yesterday was a milestone moment for Corify Care. We returned to where it all began—Hospital Gregorio Marañón—to officially present our non-invasive cardiac...